RT Journal Article
SR Electronic
T1 γ-Secretase Inhibitors Induce Erythroid Differentiation in Erythroid Leukemia Cell Lines
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 4071
OP 4074
VO 30
IS 10
A1 OKUHASHI, YUKI
A1 ITOH, MAI
A1 ARAI, AYAKO
A1 NARA, NOBUO
A1 TOHDA, SHUJI
YR 2010
UL http://ar.iiarjournals.org/content/30/10/4071.abstract
AB Background: Notch signaling regulates the fate of hematopoietic stem cells and leukemia cells. However, the role of Notch in erythroid differentiation remains unclear. Materials and Methods: We examined the effects of three γ-secretase inhibitors (GSI-IX, GSI-XII and GSI-XXI) that inhibit Notch signaling on the in vitro growth and differentiation of HEL and AA erythroid leukemia cell lines. Results: GSI treatment induced morphologic erythroid differentiation and promoted hemoglobin production. GSI treatment suppressed short-term growth and colony formation, while treatment with GSI-XXI promoted the growth of AA cells. The degree of differentiation induced by each GSI roughly correlated with the reduction in HES1 mRNA expression. Conclusion: GSIs have potential uses in differentiation induction therapy for erythroid leukemia in the future. Before clinical use, in vitro sensitivity tests should be performed because the effects of GSIs are diverse depending upon the combination of leukemia cells and GSIs.